180 related articles for article (PubMed ID: 17187753)
1. Discovery and development of a type II collagen neoepitope (TIINE) biomarker for matrix metalloproteinase activity: from in vitro to in vivo.
Nemirovskiy OV; Dufield DR; Sunyer T; Aggarwal P; Welsch DJ; Mathews WR
Anal Biochem; 2007 Feb; 361(1):93-101. PubMed ID: 17187753
[TBL] [Abstract][Full Text] [Related]
2. Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: A biomarker of matrix metalloproteinase activity and osteoarthritis in human urine.
Li WW; Nemirovskiy O; Fountain S; Rodney Mathews W; Szekely-Klepser G
Anal Biochem; 2007 Oct; 369(1):41-53. PubMed ID: 17570334
[TBL] [Abstract][Full Text] [Related]
3. Design and validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide in human urine: application as a biomarker of osteoarthritis.
Nemirovskiy O; Li WW; Szekely-Klepser G
Methods Mol Biol; 2010; 641():253-70. PubMed ID: 20407952
[TBL] [Abstract][Full Text] [Related]
4. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
[TBL] [Abstract][Full Text] [Related]
5. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
6. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
7. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.
Billinghurst RC; Dahlberg L; Ionescu M; Reiner A; Bourne R; Rorabeck C; Mitchell P; Hambor J; Diekmann O; Tschesche H; Chen J; Van Wart H; Poole AR
J Clin Invest; 1997 Apr; 99(7):1534-45. PubMed ID: 9119997
[TBL] [Abstract][Full Text] [Related]
8. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13.
Wu W; Billinghurst RC; Pidoux I; Antoniou J; Zukor D; Tanzer M; Poole AR
Arthritis Rheum; 2002 Aug; 46(8):2087-94. PubMed ID: 12209513
[TBL] [Abstract][Full Text] [Related]
9. An immunoaffinity liquid chromatography-tandem mass spectrometry assay for detection of endogenous aggrecan fragments in biological fluids: Use as a biomarker for aggrecanase activity and cartilage degradation.
Dufield DR; Nemirovskiy OV; Jennings MG; Tortorella MD; Malfait AM; Mathews WR
Anal Biochem; 2010 Nov; 406(2):113-23. PubMed ID: 20603097
[TBL] [Abstract][Full Text] [Related]
10. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
11. Online immunoaffinity liquid chromatography/tandem mass spectrometry determination of a type II collagen peptide biomarker in rat urine: Investigation of the impact of collision-induced dissociation fluctuation on peptide quantitation.
Berna M; Schmalz C; Duffin K; Mitchell P; Chambers M; Ackermann B
Anal Biochem; 2006 Sep; 356(2):235-43. PubMed ID: 16797470
[TBL] [Abstract][Full Text] [Related]
12. Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: implications for development and arthritis.
Tchetina EV; Kobayashi M; Yasuda T; Meijers T; Pidoux I; Poole AR
Matrix Biol; 2007 May; 26(4):247-58. PubMed ID: 17306969
[TBL] [Abstract][Full Text] [Related]
13. Discovery and development of the N-terminal procollagen type II (NPII) biomarker: a tool for measuring collagen type II synthesis.
Nemirovskiy OV; Sunyer T; Aggarwal P; Abrams M; Hellio Le Graverand MP; Mathews WR
Osteoarthritis Cartilage; 2008 Dec; 16(12):1494-500. PubMed ID: 18556223
[TBL] [Abstract][Full Text] [Related]
14. Endothelin 1 promotes osteoarthritic cartilage degradation via matrix metalloprotease 1 and matrix metalloprotease 13 induction.
Roy-Beaudry M; Martel-Pelletier J; Pelletier JP; M'Barek KN; Christgau S; Shipkolye F; Moldovan F
Arthritis Rheum; 2003 Oct; 48(10):2855-64. PubMed ID: 14558091
[TBL] [Abstract][Full Text] [Related]
15. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.
Mitchell PG; Magna HA; Reeves LM; Lopresti-Morrow LL; Yocum SA; Rosner PJ; Geoghegan KF; Hambor JE
J Clin Invest; 1996 Feb; 97(3):761-8. PubMed ID: 8609233
[TBL] [Abstract][Full Text] [Related]
16. Involvement of CD44 in induction of matrix metalloproteinases by a COOH-terminal heparin-binding fragment of fibronectin in human articular cartilage in culture.
Yasuda T; Poole AR; Shimizu M; Nakagawa T; Julovi SM; Tamamura H; Fujii N; Nakamura T
Arthritis Rheum; 2003 May; 48(5):1271-80. PubMed ID: 12746900
[TBL] [Abstract][Full Text] [Related]
17. Telopeptides of type II collagen upregulate proteinases and damage cartilage but are less effective than highly active fibronectin fragments.
Guo D; Ding L; Homandberg GA
Inflamm Res; 2009 Mar; 58(3):161-9. PubMed ID: 19190855
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel immunoassay for the measurement of type II collagen neoepitope generated by collagenase cleavage.
Takahashi T; Naito S; Onoda J; Yamauchi A; Nakamura E; Kishino J; Kawai T; Matsukawa S; Toyosaki-Maeda T; Tanimura M; Fukui N; Numata Y; Yamane S
Clin Chim Acta; 2012 Oct; 413(19-20):1591-9. PubMed ID: 22507082
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis.
Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS
Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343
[TBL] [Abstract][Full Text] [Related]
20. Collagen degradation products modulate matrix metalloproteinase expression in cultured articular chondrocytes.
Fichter M; Körner U; Schömburg J; Jennings L; Cole AA; Mollenhauer J
J Orthop Res; 2006 Jan; 24(1):63-70. PubMed ID: 16419970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
